mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
mRNA |
Axitinib |
FIMM |
pan-cancer |
AAC |
0.011 |
0.9 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
-0.0078 |
0.9 |
mRNA |
Doxorubicin |
FIMM |
pan-cancer |
AAC |
-0.0098 |
0.9 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
0.9 |
mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |